InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Jun 26, 2026, 4:00 PM EDT
1.010
-0.030 (-2.88%)
After-hours: Jun 26, 2026, 6:26 PM EDT
InterCure Market Cap
InterCure has a market cap or net worth of $57.73 million as of June 26, 2026. Its market cap has decreased by -21.38% in one year.
Market Cap
57.73M
Enterprise Value
103.13M
1-Year Change
-21.38%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from $1.78M to $57.73M, an increase of 3,141.15%. That is a compound annual growth rate of 25.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 57.73M | 4.01% |
| Dec 31, 2025 | 55.50M | -25.61% |
| Dec 31, 2024 | 74.61M | 27.32% |
| Dec 31, 2023 | 58.60M | -62.52% |
| Dec 29, 2022 | 156.35M | -47.90% |
| Dec 30, 2021 | 300.11M | 119.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BGM Group | 124.06M |
| Cardiol Therapeutics | 122.68M |
| Cumberland Pharmaceuticals | 101.14M |
| Citius Oncology | 57.65M |
| Talphera | 53.46M |
| Incannex Healthcare | 40.92M |
| BioXcel Therapeutics | 40.45M |
| SCYNEXIS | 38.23M |